tiprankstipranks
NervGen Pharma (TSE:NGEN)
:NGEN
Canadian Market

NervGen Pharma (NGEN) Financial Statements

Compare
35 Followers

NervGen Pharma Financial Overview

NervGen Pharma's market cap is currently $203.53M. The company's EPS TTM is C$-0.369; its P/E ratio is ―; NervGen Pharma is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -145.00KC$ -115.11KC$ -42.63KC$ -39.65KC$ -38.22K
Operating IncomeC$ -17.78MC$ -22.82MC$ -12.87MC$ -11.19MC$ -9.86M
EBITDAC$ -17.72MC$ -20.09MC$ -12.77MC$ -11.16MC$ -9.83M
Net IncomeC$ -22.38MC$ -18.11MC$ -12.64MC$ -11.18MC$ -9.67M
Balance Sheet
Cash & Short-Term InvestmentsC$ 11.66MC$ 22.45MC$ 16.93MC$ 5.60MC$ 4.11M
Total AssetsC$ 13.24MC$ 23.88MC$ 17.90MC$ 6.68MC$ 6.77M
Total DebtC$ 197.19KC$ 283.45KC$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -11.46MC$ -22.17MC$ -16.93MC$ -5.60MC$ -4.11M
Total LiabilitiesC$ 15.25MC$ 10.41MC$ 1.08MC$ 755.07KC$ 923.95K
Stockholders' EquityC$ -2.01MC$ 13.46MC$ 16.82MC$ 5.92MC$ 5.84M
Cash Flow
Free Cash FlowC$ -11.44MC$ -17.81MC$ -8.31MC$ -6.31MC$ -8.09M
Operating Cash FlowC$ -11.30MC$ -17.78MC$ -8.27MC$ -6.31MC$ -8.09M
Investing Cash FlowC$ -138.85KC$ -21.11KC$ -45.09KC$ -3.42KC$ 0.00
Financing Cash FlowC$ 766.28KC$ 22.64MC$ 19.61MC$ 7.85MC$ 9.84M
Currency in CAD

NervGen Pharma Earnings and Revenue History

NervGen Pharma Debt to Assets

NervGen Pharma Cash Flow

NervGen Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis